Ishii Y, Hansen A J, Mackenzie P I
Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Mol Pharmacol. 2000 May;57(5):940-7.
The human UDP glucuronosyltransferase, UGT2B7, is expressed in the liver and gastrointestinal tract, where it catalyzes the glucuronidation of steroids and bile acids. In this study, the UGT2B7 gene was isolated and its proximal promoter was analyzed. The UGT2B7 gene consists of 6 exons and extends over 16 kilobases (kb). It does not contain a canonical TATA box but has a region (-2 to -40) adjacent to the transcription start site that binds nuclear proteins. This region contains a consensus hepatic nuclear factor-1alpha (HNF1alpha)-binding site and an overlapping AT-rich segment. Varying lengths of the UGT2B7 gene promoter, with and without these sites, were fused to the firefly luciferase reporter gene and transfected into HepG2 cells. UGT2B7 promoter activity with the HNF1/AT-rich element was stimulated by cotransfection with HNF1alpha. Additional activation was observed when HNF1alpha and octamer transcription factor-1 (Oct-1) were cotransfected simultaneously. However, Oct-1 alone did not stimulate promoter activity and did not bind to the promoter in the absence of HNF1alpha. Deletion of the HNF1/AT-rich region, or mutations in this region, abolished UGT2B7 gene promoter activity and prevented HNF1alpha-mediated increases in promoter activity. The presence of HNF1alpha and octamer transcription factor-1 (Oct-1) in the protein complex that bound to the HNF1/AT-rich region was demonstrated by gel shift analyses with antibodies specific to HNF1alpha and Oct-1 protein. These results strongly suggest that the liver-enriched factor HNF1alpha binds to, and activates, the UGT2B7 gene promoter and that the ubiquitous transcription factor, Oct-1, enhances this activation by directly interacting with HNF1alpha. This interaction between HNF1alpha and Oct-1 may fine-tune UGT2B7 expression.
人类尿苷二磷酸葡萄糖醛酸基转移酶UGT2B7在肝脏和胃肠道中表达,在这些部位它催化类固醇和胆汁酸的葡萄糖醛酸化反应。在本研究中,UGT2B7基因被分离出来并对其近端启动子进行了分析。UGT2B7基因由6个外显子组成,跨越16千碱基(kb)。它不包含典型的TATA盒,但在转录起始位点附近有一个区域(-2至-40)能结合核蛋白。该区域包含一个共有肝细胞核因子-1α(HNF1α)结合位点和一个重叠的富含AT的片段。将含有和不含有这些位点的不同长度的UGT2B7基因启动子与萤火虫荧光素酶报告基因融合,并转染到HepG2细胞中。与HNF1α共转染可刺激含有HNF1/富含AT元件的UGT2B7启动子活性。当HNF1α和八聚体转录因子-1(Oct-1)同时共转染时,可观察到额外的激活作用。然而,单独的Oct-1不会刺激启动子活性,且在没有HNF1α的情况下不会与启动子结合。HNF1/富含AT区域的缺失或该区域的突变会消除UGT2B7基因启动子活性,并阻止HNF1α介导的启动子活性增加。通过使用针对HNF1α和Oct-1蛋白的特异性抗体进行凝胶迁移分析,证明了与HNF1/富含AT区域结合的蛋白质复合物中存在HNF1α和八聚体转录因子-1(Oct-1)。这些结果强烈表明,肝脏富集因子HNF1α结合并激活UGT2B7基因启动子,并且普遍存在的转录因子Oct-1通过直接与HNF1α相互作用增强这种激活作用。HNF1α和Oct-1之间的这种相互作用可能会微调UGT2B7的表达。